Skip to Content
138

Bristol-Myers Squibb

  • Previous Rank145
  • Revenues ($M)$22,561.0
  • Revenue Percent Change8.6%
  • Profits ($M)$4,920.0
  • Profits Percent Change388.6%
  • Assets ($M)$34,986.0
  • Employees23,300

The biopharmaceutical company manufactures medicines for Alzheimer’s, dementia, psychiatric disorders, cardiovascular, diabetes, oncology, and hepatitis.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
Giovanni Caforio
CEO Title
Chairman & Chief Executive Officer
Sector
Health Care
Industry
Pharmaceuticals
HQ Location
New York, N.Y.
Websitehttp://www.bms.com
Years on Fortune 500 List65
Employees23,300

Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$22,561.08.6%
Profits ($M)$4,920.0388.6%
Assets ($M)$34,986.0-
Total Stockholder Equity ($M)$14,031.0-

Profit Ratios

Profit as % of Revenues21.8%
Profits as % of Assets14.1%
Profits as % of Stockholder Equity35.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)3.01
EPS % Change (from 2017)393.4%
EPS % Change (5 year annual rate)14.3%
EPS % Change (10 year annual rate)1.4%

Total Return

Total Return to Investors (2018)-12.7%
Total Return to Investors (5 year, annualized)2.2%
Total Return to Investors (10 year, annualized)12.3%